ResMed RMD Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $398.73M+1.6% | $392.59M+12.6% | $348.54M-8.2% | $379.71M+4.0% | $365.04M+5.9% | ||
| $58.98M+18.2% | $49.89M+4.6% | $47.7M-25.0% | $63.63M+45.7% | $43.68M-6.0% | ||
| $26.79M-7.4% | $28.94M+36.8% | $21.16M-14.5% | $24.75M+2.6% | $24.12M+6.6% | ||
| $554.13M+63.1% | $339.75M-25.7% | $457.32M-15.1% | $538.77M-6.9% | $578.66M+87.5% | ||
| $33.65M+17.9% | $28.54M-33.6% | $42.97M+40.5% | $30.59M+47.1% | $20.8M+0.7% | ||
| $24.88M— | —— | $522K-99.6% | $138.58M— | $0-100% | ||
| -$58.03M-13.9% | -$50.94M+3.1% | -$52.58M+60.7% | -$133.71M-321% | -$31.79M+13.4% | ||
| $87.24M-0.4% | $87.58M-0.2% | $87.75M+13.1% | $77.59M-0.1% | $77.7M0.0% | ||
| $175.01M0.0% | $175.01M+16.7% | $150.01M+50.0% | $100.01M+33.3% | $75.03M+0.1% | ||
| —— | $5M— | $0-100% | $5M— | $0-100% | ||
| -$255.24M+1.2% | -$258.35M-12.2% | -$230.27M-40.5% | -$163.89M-13.8% | -$144.07M+2.3% | ||
| $243.44M+633% | $33.22M-81.0% | $174.4M-37.0% | $276.74M-32.6% | $410.77M+330% | ||
| $520.48M+67.2% | $311.21M-24.9% | $414.36M-18.5% | $508.18M-8.9% | $557.87M+93.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ResMed generate?
- ResMed (RMD) generated $1.9B in operating cash flow over the trailing twelve months.
- What is ResMed's free cash flow?
- After $135.7M of capital expenditures, ResMed's free cash flow was $1.8B over the trailing twelve months, up 11.8% year over year.
- Where does ResMed's cash flow data come from?
- Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
